These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 22020294)

  • 1. MEK5/ERK5 pathway: the first fifteen years.
    Drew BA; Burow ME; Beckman BS
    Biochim Biophys Acta; 2012 Jan; 1825(1):37-48. PubMed ID: 22020294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The MEK5/ERK5 signalling pathway in cancer: a promising novel therapeutic target.
    Simões AE; Rodrigues CM; Borralho PM
    Drug Discov Today; 2016 Oct; 21(10):1654-1663. PubMed ID: 27320690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic signaling of MEK5-ERK5.
    Hoang VT; Yan TJ; Cavanaugh JE; Flaherty PT; Beckman BS; Burow ME
    Cancer Lett; 2017 Apr; 392():51-59. PubMed ID: 28153789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological inhibition of the MEK5/ERK5 and PI3K/Akt signaling pathways synergistically reduces viability in triple-negative breast cancer.
    Wright TD; Raybuck C; Bhatt A; Monlish D; Chakrabarty S; Wendekier K; Gartland N; Gupta M; Burow ME; Flaherty PT; Cavanaugh JE
    J Cell Biochem; 2020 Feb; 121(2):1156-1168. PubMed ID: 31464004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic analysis of tumor necrosis factor-alpha resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype.
    Zhou C; Nitschke AM; Xiong W; Zhang Q; Tang Y; Bloch M; Elliott S; Zhu Y; Bazzone L; Yu D; Weldon CB; Schiff R; McLachlan JA; Beckman BS; Wiese TE; Nephew KP; Shan B; Burow ME; Wang G
    Breast Cancer Res; 2008; 10(6):R105. PubMed ID: 19087274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual inhibition of MEK1/2 and MEK5 suppresses the EMT/migration axis in triple-negative breast cancer through FRA-1 regulation.
    Hoang VT; Matossian MD; La J; Hoang K; Ucar DA; Elliott S; Burks HE; Wright TD; Patel S; Bhatt A; Phamduy T; Chrisey D; Buechlein A; Rusch DB; Nephew KP; Anbalagan M; Rowan B; Cavanaugh JE; Flaherty PT; Miele L; Collins-Burow BM; Burow ME
    J Cell Biochem; 2021 Aug; 122(8):835-850. PubMed ID: 33876843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A kinome-wide high-content siRNA screen identifies MEK5-ERK5 signaling as critical for breast cancer cell EMT and metastasis.
    Pavan S; Meyer-Schaller N; Diepenbruck M; Kalathur RKR; Saxena M; Christofori G
    Oncogene; 2018 Aug; 37(31):4197-4213. PubMed ID: 29713055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MEK5/ERK5 signaling suppresses estrogen receptor expression and promotes hormone-independent tumorigenesis.
    Antoon JW; Martin EC; Lai R; Salvo VA; Tang Y; Nitzchke AM; Elliott S; Nam SY; Xiong W; Rhodes LV; Collins-Burow B; David O; Wang G; Shan B; Beckman BS; Nephew KP; Burow ME
    PLoS One; 2013; 8(8):e69291. PubMed ID: 23950888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted Avenues for Cancer Treatment: The MEK5-ERK5 Signaling Pathway.
    Pereira DM; Rodrigues CMP
    Trends Mol Med; 2020 Apr; 26(4):394-407. PubMed ID: 32277933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The MEK5-ERK5 Kinase Axis Controls Lipid Metabolism in Small-Cell Lung Cancer.
    Cristea S; Coles GL; Hornburg D; Gershkovitz M; Arand J; Cao S; Sen T; Williamson SC; Kim JW; Drainas AP; He A; Cam LL; Byers LA; Snyder MP; Contrepois K; Sage J
    Cancer Res; 2020 Mar; 80(6):1293-1303. PubMed ID: 31969375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MEK5/ERK5 signaling inhibition increases colon cancer cell sensitivity to 5-fluorouracil through a p53-dependent mechanism.
    Pereira DM; Simões AE; Gomes SE; Castro RE; Carvalho T; Rodrigues CM; Borralho PM
    Oncotarget; 2016 Jun; 7(23):34322-40. PubMed ID: 27144434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of pharmacological inhibitors of the MEK5/ERK5 pathway.
    Tatake RJ; O'Neill MM; Kennedy CA; Wayne AL; Jakes S; Wu D; Kugler SZ; Kashem MA; Kaplita P; Snow RJ
    Biochem Biophys Res Commun; 2008 Dec; 377(1):120-5. PubMed ID: 18834865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MEK5/ERK5 Pathway in Health and Disease.
    Paudel R; Fusi L; Schmidt M
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirement of the MEK5-ERK5 pathway for neural differentiation in Xenopus embryonic development.
    Nishimoto S; Kusakabe M; Nishida E
    EMBO Rep; 2005 Nov; 6(11):1064-9. PubMed ID: 16179948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YAP promotes myogenic differentiation
    Chen TH; Chen CY; Wen HC; Chang CC; Wang HD; Chuu CP; Chang CH
    FASEB J; 2017 Jul; 31(7):2963-2972. PubMed ID: 28356344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-redundant function of the MEK5-ERK5 pathway in thymocyte apoptosis.
    Sohn SJ; Lewis GM; Winoto A
    EMBO J; 2008 Jul; 27(13):1896-906. PubMed ID: 18548009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ERK5 activation is essential for osteoclast differentiation.
    Amano S; Chang YT; Fukui Y
    PLoS One; 2015; 10(4):e0125054. PubMed ID: 25885811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The MEK5/ERK5 pathway mediates fluid shear stress promoted osteoblast differentiation.
    Zhao LG; Chen SL; Teng YJ; An LP; Wang J; Ma JL; Xia YY
    Connect Tissue Res; 2014 Apr; 55(2):96-102. PubMed ID: 24111522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The MEK5/ERK5 mitogen-activated protein kinase cascade is an effector pathway of bone-sustaining bisphosphonates that regulates osteogenic differentiation and mineralization.
    Adam C; Glück L; Ebert R; Goebeler M; Jakob F; Schmidt M
    Bone; 2018 Jun; 111():49-58. PubMed ID: 29567200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to MAPK Inhibitors in Melanoma Involves Activation of the IGF1R-MEK5-Erk5 Pathway.
    Benito-Jardón L; Díaz-Martínez M; Arellano-Sánchez N; Vaquero-Morales P; Esparís-Ogando A; Teixidó J
    Cancer Res; 2019 May; 79(9):2244-2256. PubMed ID: 30833419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.